Walmart U.S. comparable sales excluding fuel rose 2.6% in the second quarter ended July 31, 2026, reflecting a clear deceleration from the 4.6% growth posted in the prior-year period. The result incorporated an 80–125 basis point headwind from the health and wellness segment, driven by pharmacy deflation and the impact of maximum fair price regulation on brand-to-generic shifts. These factors, combined with broader pressure on consumer spending and thousands of price reductions, pulled growth below the 3% threshold and aligned with the market-implied odds now at 100% for the sub-3% outcome. Resolution will follow formal confirmation in the earnings release, though any material restatement remains unlikely given the reported figure.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日3%未満 100.0%
3%~4.5% <1%
4.5%-6% <1%
6%~7.5% <1%
$6,564 Vol.
$6,564 Vol.
3%未満
はい
3%~4.5%
いいえ
4.5%-6%
いいえ
6%~7.5%
いいえ
7.5%以上
いいえ
3%未満 100.0%
3%~4.5% <1%
4.5%-6% <1%
6%~7.5% <1%
$6,564 Vol.
$6,564 Vol.
3%未満
はい
3%~4.5%
いいえ
4.5%-6%
いいえ
6%~7.5%
いいえ
7.5%以上
いいえ
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by September 30, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
マーケット開始日: Aug 4, 2026, 5:36 PM ET
リゾルバー
0x69c47De9D...提案された結果: はい
異議申し立てなし
最終結果: はい
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.
If the specified company does not release quarterly earnings materials for the specified quarter by September 30, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.
If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
リゾルバー
0x69c47De9D...提案された結果: はい
異議申し立てなし
最終結果: はい
Walmart U.S. comparable sales excluding fuel rose 2.6% in the second quarter ended July 31, 2026, reflecting a clear deceleration from the 4.6% growth posted in the prior-year period. The result incorporated an 80–125 basis point headwind from the health and wellness segment, driven by pharmacy deflation and the impact of maximum fair price regulation on brand-to-generic shifts. These factors, combined with broader pressure on consumer spending and thousands of price reductions, pulled growth below the 3% threshold and aligned with the market-implied odds now at 100% for the sub-3% outcome. Resolution will follow formal confirmation in the earnings release, though any material restatement remains unlikely given the reported figure.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日


外部リンクに注意してください。
外部リンクに注意してください。
よくある質問